A large phase 3 clinical trial has revealed promising results for a once-nightly pill designed to treat obstructive sleep ...
July 26 (UPI) --Cardiovascular risks linked to sleep apnea are caused by a reduction in blood oxygen levels, according to National Institutes of Health-supported study published in the American ...
The first-ever sleep apnea pill cut breathing episodes by over 50% in Phase 3 trials. Here's the data and when to expect FDA ...
Share on Pinterest Lower blood oxygen levels due to sleep apnea may explain the higher cardiovascular risk faced by people with this condition. Image credit: milorad kravic/Getty Images. A new study ...
Please provide your email address to receive an email when new articles are posted on . In a new study, the use of CPAP and high-flow nasal oxygen to treat patients with moderate to severe COVID-19 ...
Based in Tampa, Florida, Virginia Pelley is a former women's magazine editor who has written health and fitness content for Men's Journal, Cosmopolitan magazine, the Chicago Tribune, ...
Sleep often gets pushed to the bottom of the priority list. Busy schedules, family obligations, and endless distractions make ...
Sleep apnea and low oxygen levels while sleeping are associated with epilepsy that first occurs after 60 years of age, known as late-onset epilepsy, according to a new study funded by the National ...
Researchers found a gut-related receptor tied to heart damage from sleep apnea, offering a potential new treatment target.
Studies in mice reveal a new target for potentially treating and preventing life-threatening cardiovascular complications in ...
Studies in mice reveal a new target for potentially treating and preventing life-threatening cardiovascular complications in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results